United States · FDA National Drug Code directory
Bromocriptine mesylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0574-0106_3a655bc4-d44e-4dd2-a951-211d8484f788
- Product NDC
- 0574-0106
- Form
- TABLET
- Composition / generic term
- Bromocriptine mesylate
- Labeler
- Padagis US LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20140401
- Source listing expiry
- 20261231
Source-listed ingredients
- BROMOCRIPTINE MESYLATE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (0574-0106-01) · 0574-0106-01
- 30 TABLET in 1 BOTTLE, PLASTIC (0574-0106-03) · 0574-0106-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →